Amalgamated Bank’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-650
Closed -$17K 2051
2025
Q4
$17K Sell
650
-106
-14% -$2.75K ﹤0.01% 2180
2025
Q3
$17K Hold
756
﹤0.01% 2195
2025
Q2
$15K Hold
756
﹤0.01% 2235
2025
Q1
$13K Sell
756
-5,232
-87% -$89.1K ﹤0.01% 2246
2024
Q4
$111K Hold
5,988
﹤0.01% 1683
2024
Q3
$130K Buy
5,988
+79
+1% +$1.77K ﹤0.01% 1658
2024
Q2
$116K Sell
5,909
-783
-12% -$16.3K ﹤0.01% 1691
2024
Q1
$145K Sell
6,692
-348
-5% -$8.64K ﹤0.01% 1662
2023
Q4
$204K Sell
7,040
-1,082
-13% -$29K ﹤0.01% 1786
2023
Q3
$217K Hold
8,122
﹤0.01% 1759
2023
Q2
$301K Sell
8,122
-288
-3% -$10K ﹤0.01% 1668
2023
Q1
$263K Sell
8,410
-764
-8% -$24.6K ﹤0.01% 1697
2022
Q4
$273K Sell
9,174
-177
-2% -$6.33K ﹤0.01% 1737
2022
Q3
$356K Buy
9,351
+245
+3% +$12.3K ﹤0.01% 1585
2022
Q2
$497K Buy
9,106
+95
+1% +$5.22K ﹤0.01% 1466
2022
Q1
$562K Sell
9,011
-381
-4% -$25.1K ﹤0.01% 1494
2021
Q4
$945K Sell
9,392
-66
-0.7% -$5.8K 0.01% 1261
2021
Q3
$851K Buy
9,458
+288
+3% +$26.2K 0.01% 1325
2021
Q2
$846K Buy
+9,170
New +$732K 0.01% 1367

Other funds holding FLGT

Amalgamated Bank's FLGT Position: Q1 2026 in Review

Amalgamated Bank sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 650 shares — an estimated $17K sold.

Amalgamated Bank first reported a position in FLGT in Q2 2021 and held it in 19 quarters. The position peaked at $945K in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Amalgamated Bank reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 650 Fulgent Genetics shares in Q1 2026, an estimated $17K.
  • Amalgamated Bank first reported a position in Fulgent Genetics in Q2 2021 and held it in 19 quarters.
  • Amalgamated Bank's Fulgent Genetics position peaked at $945K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.